Logo image of AMWL

AMERICAN WELL CORP-CLASS A (AMWL) Stock Fundamental Analysis

NYSE:AMWL - New York Stock Exchange, Inc. - US03044L2043 - Common Stock - Currency: USD

11.74  -0.32 (-2.65%)

Fundamental Rating

3

AMWL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 39 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for AMWL as it has an excellent financial health rating, but there are worries on the profitability. AMWL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AMWL had negative earnings in the past year.
In the past year AMWL has reported a negative cash flow from operations.
In the past 5 years AMWL always reported negative net income.
AMWL had a negative operating cash flow in each of the past 5 years.
AMWL Yearly Net Income VS EBIT VS OCF VS FCFAMWL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

AMWL has a worse Return On Assets (-47.74%) than 67.57% of its industry peers.
The Return On Equity of AMWL (-68.29%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -47.74%
ROE -68.29%
ROIC N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
AMWL Yearly ROA, ROE, ROICAMWL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

AMWL has a worse Gross Margin (38.98%) than 75.68% of its industry peers.
AMWL's Gross Margin has declined in the last couple of years.
AMWL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
AMWL Yearly Profit, Operating, Gross MarginsAMWL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

7

2. Health

2.1 Basic Checks

AMWL does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMWL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMWL has less shares outstanding
AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMWL Yearly Shares OutstandingAMWL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
AMWL Yearly Total Debt VS Total AssetsAMWL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

AMWL has an Altman-Z score of -5.94. This is a bad value and indicates that AMWL is not financially healthy and even has some risk of bankruptcy.
AMWL has a worse Altman-Z score (-5.94) than 75.68% of its industry peers.
There is no outstanding debt for AMWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.94
ROIC/WACCN/A
WACC10.18%
AMWL Yearly LT Debt VS Equity VS FCFAMWL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

AMWL has a Current Ratio of 2.85. This indicates that AMWL is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AMWL (2.85) is better than 70.27% of its industry peers.
A Quick Ratio of 2.82 indicates that AMWL has no problem at all paying its short term obligations.
AMWL has a Quick ratio of 2.82. This is in the better half of the industry: AMWL outperforms 70.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 2.82
AMWL Yearly Current Assets VS Current LiabilitesAMWL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

AMWL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.62%, which is quite impressive.
The Revenue has decreased by -1.81% in the past year.
Measured over the past years, AMWL shows a quite strong growth in Revenue. The Revenue has been growing by 11.30% on average per year.
EPS 1Y (TTM)42.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.53%
Revenue 1Y (TTM)-1.81%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%0.47%

3.2 Future

Based on estimates for the next years, AMWL will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.32% on average per year.
AMWL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.64% yearly.
EPS Next Y38.82%
EPS Next 2Y26.31%
EPS Next 3Y19.32%
EPS Next 5YN/A
Revenue Next Year9.44%
Revenue Next 2Y8.48%
Revenue Next 3Y6.91%
Revenue Next 5Y8.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMWL Yearly Revenue VS EstimatesAMWL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
AMWL Yearly EPS VS EstimatesAMWL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMWL. In the last year negative earnings were reported.
Also next year AMWL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMWL Price Earnings VS Forward Price EarningsAMWL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMWL Per share dataAMWL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

AMWL's earnings are expected to grow with 19.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.31%
EPS Next 3Y19.32%

More info and screens

0

5. Dividend

5.1 Amount

AMWL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN WELL CORP-CLASS A

NYSE:AMWL (2/21/2025, 8:04:00 PM)

11.74

-0.32 (-2.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners45.12%
Inst Owner Change-96.39%
Ins Owners5.01%
Ins Owner Change1.06%
Market Cap179.86M
Analysts70
Price Target11.67 (-0.6%)
Short Float %3.05%
Short Ratio5.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.18%
Min EPS beat(2)7.21%
Max EPS beat(2)17.15%
EPS beat(4)3
Avg EPS beat(4)3.13%
Min EPS beat(4)-29%
Max EPS beat(4)17.18%
EPS beat(8)4
Avg EPS beat(8)-19.16%
EPS beat(12)7
Avg EPS beat(12)-11.53%
EPS beat(16)11
Avg EPS beat(16)-3.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.41%
Min Revenue beat(2)-5.41%
Max Revenue beat(2)4.58%
Revenue beat(4)1
Avg Revenue beat(4)-1.12%
Min Revenue beat(4)-5.41%
Max Revenue beat(4)4.58%
Revenue beat(8)1
Avg Revenue beat(8)-2.47%
Revenue beat(12)1
Avg Revenue beat(12)-2.1%
Revenue beat(16)2
Avg Revenue beat(16)-2.26%
PT rev (1m)0%
PT rev (3m)-7.81%
EPS NQ rev (1m)2.66%
EPS NQ rev (3m)5.56%
EPS NY rev (1m)0%
EPS NY rev (3m)29.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.71
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.88
EV/EBITDA N/A
EPS(TTM)-14
EYN/A
EPS(NY)-8.57
Fwd EYN/A
FCF(TTM)-9.31
FCFYN/A
OCF(TTM)-8.31
OCFYN/A
SpS16.6
BVpS19.89
TBVpS13.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.74%
ROE -68.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.98%
FCFM N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 46.17%
Cap/Sales 5.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.85
Quick Ratio 2.82
Altman-Z -5.94
F-Score5
WACC10.18%
ROIC/WACCN/A
Cap/Depr(3y)44.83%
Cap/Depr(5y)34.13%
Cap/Sales(3y)5.21%
Cap/Sales(5y)3.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.53%
EPS Next Y38.82%
EPS Next 2Y26.31%
EPS Next 3Y19.32%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.81%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%0.47%
Revenue Next Year9.44%
Revenue Next 2Y8.48%
Revenue Next 3Y6.91%
Revenue Next 5Y8.64%
EBIT growth 1Y16.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.41%
EBIT Next 3Y26.68%
EBIT Next 5Y15.79%
FCF growth 1Y12.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.16%
OCF growth 3YN/A
OCF growth 5YN/A